Valeant Pharmaceuticals International (VRX) Q1 2017
Joseph C. Papa – Valeant Pharmaceuticals International, Inc. “So obviously, we believe our share price is not where it should be. It should be higher, to be clear. But the fact is, that’s what – where it is today. I … Continued